Dr. Reddy's Laboratories Limited American Depositary Shares (RDY)

Health Care·equity

$12.48

+2.30% today

Prices delayed about 15 minutes · cached page, can be an hour old or more

Market Census Score

50/ 100

Score level

Average

5 of 6 checks had data

Score for how it compares with the broader market is on the low side — business numbers score is above the middle.

RDY scores higher than 68% of the 1,101 tickers we compare it with (Health Care).

As of 9 October 2026, Dr. Reddy's Laboratories Limited American Depositary Shares (RDY) scores 50 out of 100 on the Market Census six-factor composite, which puts it at the Average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.

Updated 9 October 2026 · scores usually change about once a day

Key statistics

Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.

Relative volume: 0.63× 30-day average
52-week range: 11.36 – 15.67
Market cap: —
Earnings date: —
Dividend yield: 0.71%

Volume: 1,972,309
Avg. volume (30d): 3,112,434

Open: 12.33
Previous close: 12.20
Day's range (regular session): 12.33 – 12.53

The last trade can be an extended-hours trade, so it can sit outside the regular-session range.

Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.

Beta: 0.03
P/E (TTM): 31.13
EPS (TTM): 38.67

Score breakdown · six named factors

Price trend

Strength vs the market

Company finances

Insider trades

—

Market mood

Recent momentum

Each bar is one part of the score, from 0 to 100. Read what the score means.

What the score says about RDY right now

Dr. Reddy's Laboratories Limited American Depositary Shares (RDY) currently scores 50/100 on the Market Census six-factor composite, at the Average score level. RDY is +2.30% on the day and +1.88% over five sessions as of the most recent tick. Average sits in the middle. The good and the bad in RDY's data roughly balance out right now. RDY's strongest factor is company finances at 68/100 — a strong read on the company's own reported numbers. A high reading doesn't promise a near-term move. The weakest factor is strength vs the market at 30/100 — below average next to the wider market.

Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.

See RDY in the scanner

This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).

Create your account →Share on X Embed this score

Recent RDY news

Latest headlines that name Dr. Reddy's Laboratories Limited American, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).